Centers for Disease Control. Pneumocystis pneumonia—Los Angeles. MMWR Morb Mortal Wkly Rep.1981;30:250-252.
Fischl MA, Dickinson GM, LaVoie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis
for Pneumocystis carinii pneumonia in AIDS. JAMA.1988;259:1185-1189.
Centers for Disease Control and Prevention. Report of the NIH Panel to Define Principles of Theory of HIV Infection
and guidelines for the use of antiretroviral agents in HIV-infected adults
and adolescents. MMWR Morb Mortal Wkly Rep.1998;47(RR-5):1-82.
Palella FJ, Delaney KM, Moorman AC.
et al. Declining morbidity and mortality among patients with advanced human
immunodeficiency virus infection. N Engl J Med.1998;338:853-860.
Pezzotti P, Napoli PA, Acciai S.
et al. Increasing survival time after AIDS in Italy: the role of new combination
antiretroviral therapies. AIDS.1999;13:249-255.
McNaghten AD, Hanson DL, Jones JL.
et al. Effects of antiretroviral therapy and opportunistic illness primary
chemoprophylaxis on survival after AIDS diagnosis. AIDS.1999;13:1687-1695.
Vittinghoff E, Scheer S, O'Malley P.
et al. Combination antiretroviral therapy and recent declines in AIDS incidence
and mortality. J Infect Dis.1999;179:717-720.
Detels R, Munoz A, McFarlane G.
et al. Effectiveness of potent antiretroviral therapy on time to AIDS and
death in men with known HIV infection duration. JAMA.1998;280:1497-1503.
Peters KD, Kochanek KD, Murphy SL. Deaths: final data for 1996. Natl Vital Stat Rep.1998;47:1-100.
Martin JA, Smith BL, Mathews MS, Ventura SJ. Births and deaths: preliminary data for 1998. Natl Vital Stat Rep.1999;47:1-45.
Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths and prevalence—United
States, 1996. MMWR Morb Mortal Wkly Rep.1997;46:165-173.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Vol 12, No.
1. Atlanta, Ga: Centers for Disease Control and
Buehler JW, Berkelman RL, Stehr-Green JK. The completeness of AIDS surveillance. J Acquir Immune Defic Syndr.1992;5:257-264.
Klevens RM, Fleming PL, Gaines CG, Troxler S. Completeness of HIV reporting in Louisiana, USA. Int J Epidemiol.1998;27:1105.
Greenberg AE, Hindin R, Nicholas AG.
et al. The completeness of AIDS case reporting in New York City. JAMA.1993;269:2995-3001.
Rosenblum L, Buehler JW, Morgan MW.
et al. The completeness of AIDS case reporting, 1988: a multistate collaborative
surveillance project. Am J Public Health.1992;82:1495-1499.
Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol.1994;140:1016-1019.
Edlavitch SA, Baxter J. Comparability of mortality follow-up before and after the National
Death Index. Am J Epidemiol.1988;127:1164-1178.
Stampfer MJ, Willett WC, Speizer FE.
et al. Test of the National Death Index. Am J Epidemiol.1984;119:837-839.
Williams BC, Demitrack LB, Fries BE. The accuracy of the National Death Index when personal identifiers
other than social security number are used. Am J Public Health.1992;82:1145-1147.
Karon JM, Rosenberg PS, McQuillan G.
et al. Prevalence of HIV infection in the United States, 1984-1992. JAMA.1996;276:126-131.
Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance
case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep.1992;41(RR-17):1-19.
Collett D. Modelling Survival Data in Medical Research. London, England: Chapman & Hall; 1994.
Amato DA. A generalized Kaplan-Meier estimator for heterogeneous populations. Commun Stat A Theory Methods.1988;17:263-286.
Harris JE. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984-1987. JAMA.1990;263:397-401.
Lemp GF, Payne SF, Neal D.
et al. Survival trends for patients with AIDS. JAMA.1990;263:402-406.
Jones JL, Hanson DL, Dworkin MS.
et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR Morb Mortal Wkly Rep.1999;48(SS-2):1-22.
Curtis JR, Patrick DL. Race and survival time with AIDS: a synthesis of the literature. Am J Public Health.1993;83:1425-1428.
Easterbrook PJ, Keruly J, Creagh-Kirk T.
et al. Racial and ethnic differences in outcome in zidovudine-treated patients
with advanced HIV disease. JAMA.1991;266:2713-2718.
Solomon L, Stein M, Flynn C. Health services use by urban women with or at risk for HIV-1 infection:
the HIV epidemiology research study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol.1998;17:253-261.
Shapiro MF, Morton SC, McCaffrey DF.
et al. Variations in the care of HIV-infected adults in the United States. JAMA.1999;281:2305-2315.
Rothenberg R, Woelfel M, Stoneburner R.
et al. Survival with the acquired immunodeficiency syndrome: experience with
5833 cases in New York City. N Engl J Med.1987;317:1297-1302.
Blum S, Tejinder PS, Gibbons J.
et al. Trends in survival among persons with acquired immunodeficiency syndrome
in New York City. Am J Epidemiol.1994;139:351-361.
Baillargeon J, Borucki M, Black SA, Dunn K. Determinants of survival in HIV-positive patients. Int J STD AIDS.1999;10:22-27.
Chang HG, Morse DL, Noonan C. Survival and mortality patterns of an acquired immunodeficiency syndrome
(AIDS) cohort in New York State. Am J Epidemiol.1993;138:341-349.
Hankins CA, Handley MA. HIV disease and AIDS in women: current knowledge and a research agenda. J Acquir Immune Defic Syndr.1992;5:957-971.
Moncroft A, Johnson MA, Phillips AN. Factors affecting survival in patients with the acquired immunodeficiency
Tu SM, Meng X-L, Pagano M. Survival differences and trends in patients with AIDS in the United
States. J Acquir Immune Defic Syndr.1993;6:1150-1156.
Chu SY, Farizo K, Hanson D.
et al. Capturing HIV-related mortality—effect of the 1993 expanded AIDS
surveillance definition. From: Ninth International Conference on AIDS; June 6-11, 1993; Berlin,
Germany. Abstract WS-Co1-5.
Lobato MN, Klevens RM, Li J.
et al. Unreported AIDS-defining opportunistic illnesses in persons reported
with HIV-related severe immunosuppression. J Acquir Immune Defic Syndr.1999;22:71-74.